212 related articles for article (PubMed ID: 34948242)
1. Identification of Novel Therapeutic Targets for Polyglutamine Diseases That Target Mitochondrial Fragmentation.
Traa A; Machiela E; Rudich PD; Soo SK; Senchuk MM; Van Raamsdonk JM
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948242
[TBL] [Abstract][Full Text] [Related]
2. Effects of overexpression of huntingtin proteins on mitochondrial integrity.
Wang H; Lim PJ; Karbowski M; Monteiro MJ
Hum Mol Genet; 2009 Feb; 18(4):737-52. PubMed ID: 19039036
[TBL] [Abstract][Full Text] [Related]
3. Targeting Mitochondrial Network Disorganization is Protective in
Machiela E; Rudich PD; Traa A; Anglas U; Soo SK; Senchuk MM; Van Raamsdonk JM
Aging Dis; 2021 Oct; 12(7):1753-1772. PubMed ID: 34631219
[TBL] [Abstract][Full Text] [Related]
4. Disruption of mitochondrial dynamics affects behaviour and lifespan in Caenorhabditis elegans.
Byrne JJ; Soh MS; Chandhok G; Vijayaraghavan T; Teoh JS; Crawford S; Cobham AE; Yapa NMB; Mirth CK; Neumann B
Cell Mol Life Sci; 2019 May; 76(10):1967-1985. PubMed ID: 30840087
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress is increased in C. elegans models of Huntington's disease but does not contribute to polyglutamine toxicity phenotypes.
Machiela E; Dues DJ; Senchuk MM; Van Raamsdonk JM
Neurobiol Dis; 2016 Dec; 96():1-11. PubMed ID: 27544481
[TBL] [Abstract][Full Text] [Related]
6. Drp1/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington's disease.
Joshi AU; Ebert AE; Haileselassie B; Mochly-Rosen D
J Mol Cell Cardiol; 2019 Feb; 127():125-133. PubMed ID: 30550751
[TBL] [Abstract][Full Text] [Related]
7. S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease.
Haun F; Nakamura T; Shiu AD; Cho DH; Tsunemi T; Holland EA; La Spada AR; Lipton SA
Antioxid Redox Signal; 2013 Oct; 19(11):1173-84. PubMed ID: 23641925
[TBL] [Abstract][Full Text] [Related]
8. Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission.
Reddy PH
Drug Discov Today; 2014 Jul; 19(7):951-5. PubMed ID: 24681059
[TBL] [Abstract][Full Text] [Related]
9. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.
Bates EA; Victor M; Jones AK; Shi Y; Hart AC
J Neurosci; 2006 Mar; 26(10):2830-8. PubMed ID: 16525063
[TBL] [Abstract][Full Text] [Related]
10. ATAD3A oligomerization causes neurodegeneration by coupling mitochondrial fragmentation and bioenergetics defects.
Zhao Y; Sun X; Hu D; Prosdocimo DA; Hoppel C; Jain MK; Ramachandran R; Qi X
Nat Commun; 2019 Mar; 10(1):1371. PubMed ID: 30914652
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli.
Costa V; Giacomello M; Hudec R; Lopreiato R; Ermak G; Lim D; Malorni W; Davies KJ; Carafoli E; Scorrano L
EMBO Mol Med; 2010 Dec; 2(12):490-503. PubMed ID: 21069748
[TBL] [Abstract][Full Text] [Related]
12. Glucose effects on polyglutamine-induced proteotoxic stress in Caenorhabditis elegans.
Gatrell L; Wilkins W; Rana P; Farris M
Biochem Biophys Res Commun; 2020 Feb; 522(3):709-715. PubMed ID: 31785809
[TBL] [Abstract][Full Text] [Related]
13. Diphenyl diselenide protects a Caenorhabditis elegans model for Huntington's disease by activation of the antioxidant pathway and a decrease in protein aggregation.
Bicca Obetine Baptista F; Arantes LP; Machado ML; da Silva AF; Marafiga Cordeiro L; da Silveira TL; Soares FAA
Metallomics; 2020 Jul; 12(7):1142-1158. PubMed ID: 32453327
[TBL] [Abstract][Full Text] [Related]
14. Genetic and pharmacological suppression of polyglutamine-dependent neuronal dysfunction in Caenorhabditis elegans.
Parker JA; Holbert S; Lambert E; Abderrahmane S; Néri C
J Mol Neurosci; 2004; 23(1-2):61-8. PubMed ID: 15126693
[TBL] [Abstract][Full Text] [Related]
15. Drp1 phosphorylation by MAPK1 causes mitochondrial dysfunction in cell culture model of Huntington's disease.
Roe AJ; Qi X
Biochem Biophys Res Commun; 2018 Feb; 496(2):706-711. PubMed ID: 29397067
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial translation and dynamics synergistically extend lifespan in C. elegans through HLH-30.
Liu YJ; McIntyre RL; Janssens GE; Williams EG; Lan J; van Weeghel M; Schomakers B; van der Veen H; van der Wel NN; Yao P; Mair WB; Aebersold R; MacInnes AW; Houtkooper RH
J Cell Biol; 2020 Jun; 219(6):. PubMed ID: 32259199
[TBL] [Abstract][Full Text] [Related]
17. CED-9 and mitochondrial homeostasis in C. elegans muscle.
Tan FJ; Husain M; Manlandro CM; Koppenol M; Fire AZ; Hill RB
J Cell Sci; 2008 Oct; 121(Pt 20):3373-82. PubMed ID: 18827010
[TBL] [Abstract][Full Text] [Related]
18. Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease.
Reddy PH; Shirendeb UP
Biochim Biophys Acta; 2012 Feb; 1822(2):101-10. PubMed ID: 22080977
[TBL] [Abstract][Full Text] [Related]
19. Disruption of mitochondrial dynamics increases stress resistance through activation of multiple stress response pathways.
Machiela E; Liontis T; Dues DJ; Rudich PD; Traa A; Wyman L; Kaufman C; Cooper JF; Lew L; Nadarajan S; Senchuk MM; Van Raamsdonk JM
FASEB J; 2020 Jun; 34(6):8475-8492. PubMed ID: 32385951
[TBL] [Abstract][Full Text] [Related]
20. C. elegans longevity pathways converge to decrease mitochondrial membrane potential.
Lemire BD; Behrendt M; DeCorby A; Gásková D
Mech Ageing Dev; 2009 Jul; 130(7):461-5. PubMed ID: 19442682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
